ALHAMADANI, I.; ALZYADI, M.; MAJEED, M. Prognostic Significance of the CXCL11/CXCL9/CD163 Immune Signature in Triple-Negative Breast Cancer: A Bioinformatics and Survival Analysis: CXCL11/CXCL9 prognostic value. Archives of Breast Cancer, [S. l.], v. 13, n. 2, p. 154–165, 2026. DOI: 10.32768/abc.6274819305-647. Disponível em: https://www.archbreastcancer.com/index.php/abc/article/view/1224. Acesso em: 30 may. 2026.